Search

Your search keyword '"PORTMAN, MICHAEL A."' showing total 707 results

Search Constraints

Start Over You searched for: Author "PORTMAN, MICHAEL A." Remove constraint Author: "PORTMAN, MICHAEL A."
707 results on '"PORTMAN, MICHAEL A."'

Search Results

3. Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry.

4. Cardiac Biomarkers Aid in Differentiation of Kawasaki Disease from Multisystem Inflammatory Syndrome in Children Associated with COVID-19

5. Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension

6. COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry

7. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives

8. Temporal clustering of Kawasaki disease cases around the world.

9. Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry

10. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

11. Shear stress associated with cardiopulmonary bypass induces expression of inflammatory cytokines and necroptosis in monocytes.

12. Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children

14. Development and Utility of Quality Metrics for Ambulatory Pediatric Cardiology in Kawasaki Disease

15. Abstract 16216: Sociodemographic Disparities in Severity of Multisystem Inflammatory Syndrome in Children: The National MUSIC Study

16. Abstract 15506: Pattern of Use of Anakinra for Patients With Kawasaki Disease versus Multisystem Inflammatory Syndrome in Children Associated With COVID-19

17. Abstract 15148: How Reassuring is an Initial Echocardiogram With Normal Coronary Arteries for Patients Presenting With Acute Kawasaki Disease?

20. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives

21. Absence of Pericarditis Recurrence in Rilonacept-Treated Patients with COVID-19 and SARS-CoV-2 Vaccination: Results from RHAPSODY Long-Term Extension

26. Abstract 11816: Association of Increased Adiposity and Presentation and Outcomes for Kawasaki Disease versus Multisystem Inflammatory Syndrome in Children Associated With Covid-19

28. Abstract 11464: Spectrum and Associated Factors for Coronary Artery Involvement in Kawasaki Disease versus Multisystem Inflammatory Syndrome in Children Associated With Covid-19

30. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial

32. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults

33. Pharmacogenomics of Coronary Artery Response to Intravenous Gamma Globulin in Kawasaki Disease

35. Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease

37. Objective Comparison of Clinical and Cardiac Magnetic Resonance Biomarkers in Adolescents Presenting With Acute Chest Pain and Elevated Troponins Pre‐COVID and Post‐COVID Vaccination.

39. Cardiac Biomarkers Aid in Differentiation of Kawasaki Disease from Multisystem Inflammatory Syndrome in Children Associated with COVID-19

44. Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice

45. Objective Comparison of Clinical and Cardiac Magnetic Resonance Biomarkers in Adolescents Presenting With Acute Chest Pain and Elevated Troponins Pre‐COVID and Post‐COVID Vaccination

46. Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry

47. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

48. SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children

Catalog

Books, media, physical & digital resources